Barclays Reinstated ResMed (RMD) at Underweight

April 7, 2016 7:32 AM EDT
Get Alerts RMD Hot Sheet
Price: $222.71 -0.84%

Rating Summary:
    12 Buy, 10 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 24 | New: 19
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Barclays reinstated coverage on ResMed (NYSE: RMD) with an Underweight rating and a price target of $55.00.

For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.

Shares of ResMed closed at $59.52 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities